Sarah McIntyre, MD

Specialty: Surgical Oncology
Department of Surgical Oncology

Specializing In:

  • Surgical Oncology

Research Interests:

  • Tumor genomics
  • Multimodal prognostic models
  • Clinical outcomes in GI and HPB malignancies
  • Healthcare disparities
  • Palliative care

Biography

I am a Fellow in Complex General Surgical Oncology at Roswell Park Comprehensive Cancer Center. I received my undergraduate degree from Johns Hopkins and my MD from the University of TN prior to completing General Surgery residency at NYU Langone in NYC. My clinical and academic interests include upper and lower GI malignancies, hepatobiliary tumors, melanoma, sarcoma and improving access to quality oncology care for marginalized and underserved communities.

Positions

Roswell Park Comprehensive Cancer Center

  • Surgical Oncology Fellow
  • Department of Surgical Oncology
  • Complex General Surgical Oncology

State University of New York at Buffalo

  • Clinical Assistant Instructor

Background

Education and Training

  • 2013-2017 - MD - University of TN Health Science Center, Memphis, TN
  • 2007-2011 - BA - Neuroscience, Johns Hopkins University, Baltimore, MD

Residency

  • 2017-2024 - General Surgery, New York University Langone, New York City, NY

Fellowship

  • 2020-2022 - Research Fellowship, HPB Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY

Professional Memberships

  • Alpha Omega Alpha
  • International Hepato-Pancreato-Biliary Association
  • American College of Surgeons

Professional Experience

  • 2011-2013 - HealthCorps Health Educator and Community Outreach Associate, AmeriCorps, Philadelphia, PA and New York, NY

Honors & Awards

  • 2024 - NYU Chief Resident Research Award
  • 2017 - Faculty Medal for Highest Academic Achievement

Publications

McIntyre S, Preston W, Walch H, Sharib J, Kundra R, Sigel C, Lidksy M, Allen P, Morse M, Chen W, Cercek A, Harding J, Abou-Alfa G, O’Reilly E, Park W, Balachandran P, Drebin J, Soares K, Wei W, Kingham TP, D’Angelica M, Iacobuzio-Donahue C, Jarnagin W. Concordance in Oncogenic Alterations Between Primary Tumor and Advanced Disease: Insights into the Heterogeneity of Intrahepatic Cholangiocarcinoma. JCO Precision Oncology. 2024 Feb; 8e2300534.

McIntyre S, Soares K, Chou J, D’Amico F, Shin P, Gonen M, Shia J, Balachandran P, Wei A, Kingham TP, Drebin J, Jarnagin W, D’Angelica M. Surgical Margin of Resected Colorectal Liver Metastases: How Accurate is Surgeon Prediction? Annals of Surgery. 2023 Dec.

Karagkounis G*, McIntyre S*, Wang T, Chou J, Gonen M, Balachandran V, Wei A, Soares K, Drebin J, D’Angelica M, Jarnagin W, Kingham TP. Rates and Patterns of Recurrence after Microwave Ablation of Colorectal Liver Metastases: A Per-Lesion Analysis of 416 Tumors in the Era of 2.45GHz Generators. Annals of Surgical Oncology. 2023 Oct;30(11):6571-6578. *co-first author

Soares K, Jolissaint J, McIntyre S, Seier K, Gonen M, Sigel C, Nasar N, Cercek A, Harding J, Kemeny N, Connell L, Koerkamp B, Balachandran V, D’Angelica M, Drebin J, Kingham TP, Wei A, Jarnagin W. Hepatic Disease Control in Patients with Intrahepatic Cholangiocarcinoma Correlates with Overall Survival. Cancer Medicine. 2023 Jun; 12(11):12272-12284.